Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors

Journal of Experimental Medicine

Volumn 190, Issue 1, 1999, Pages 101-111

  Zhao, Jian ^a   Ben, Li Hong ^a   Wu, Ya Lan ^a   Hu, Wei ^a   Ling, Kun ^a   Xin, Shun Mei ^a   Nie, Hui Ling ^a   Ma, Lan ^b   Pei, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Chemokine receptors; Chemotaxis; G proteins; HIV; Trichosanthin

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; TRICHOSANTHIN;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMOTAXIS; CHINESE MEDICINE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ANIMALS; ANTI-HIV AGENTS; CELL LINE; CHEMOKINES; CHEMOTAXIS; CLONING, MOLECULAR; FLUORESCENT ANTIBODY TECHNIQUE; GTP-BINDING PROTEINS; HUMANS; MICE; RABBITS; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; TRICHOSANTHIN;

EID: 0033526812     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.1.101     Document Type: Article

References (64)

1. Lui, G., F. Lui, Y. Li, and S. Yu. 1985. A summary of 402 cases of termination of early pregnancy with crystalline preparations of trichosanthin. In Advances in Chinese Medicinal Materials Research. H.-M. Chang, H.-W. Yeung, W.-W. Tso, and A. Koo, editors. World Scientific Publishing Co. Pte., Ltd., Singapore. 327-333.
2. Jin, Y.-C. 1985. Clinical study of trichosanthin. In Advances in Chinese Medicinal Materials Research. H.-M. Chang, H.-W. Yeung, W.-W. Tso, and A. Koo, editors. World Scientific Publishing Co. Pte., Ltd., Singapore. 319-325.
3. Huang, Y.L. 1987. A clinical study on treatment of malignant trophoblastic neoplasia with trichosanthin (in Chinese). Chung Hsi I Chieh Ho Tsa Chih. 7:154-155.
4. Maraganore, J.M., M. Joseph, and M.C. Bailey. 1987. Purification and characterization of trichosanthin. Homology to the ricin A chain and implications as to mechanism of abortifacient activity. J. Biol. Chem. 262:11628-11633.
5. Yeung, H.-W., W.-W. Li, Z. Feng, L. Barbieri, and F. Stirpe. 1988. Trichosanthin, alpha-momorcharin and beta-momorcharin: identity of abortifacient and ribosome-inactivating proteins. Int. J. Pept. Protein Res. 31:265-268.
6. Leung, K.-N., H.-W. Yeung, and S.-O. Leung. 1986. The immunomodulatory and antitumor activities of trichosanthin - an abortifacient protein isolated from tian-hua-fen (Trichosanthes kirilowii). Asian Pac. J. Allergy Immunol. 4:111-120.
7. Yeung, H.-W., S.P. Poon, T.B. Ng, and W.W. Li. 1987. Isolation and characterization of an immunosuppressive protein from Trichosanthes kirilowii root tubers. Immunopharmacol. Immunotoxicol. 9:25-46.
8. McGrath, M.S., S. Santulli, and I. Gaston. 1990. Effects of GLQ223 on HIV replication in human monocyte/macrophages chronically infected in vitro with HIV. AIDS Res. Hum. Retroviruses. 6:1039-1043.
9. McGrath, M.S., K.-M. Hwang, S.E. Caldwell, I. Gaston, K.C. Luk, P. Wu, V.L. Ng, S. Crowe, J. Daniels, and J. Marsh. 1989. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc. Natl. Acad. Sci. USA. 86:2844-2848.
10. Byers, V.S., A.S. Levin, A. Malvino, L. Waites, R.A. Robins, and R.W. Baldwin. 1994. A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents. AIDS Res. Hum. Retroviruses. 10:413-420.
11. Mayer, R.A., P.A. Sergios, K. Coonan, and L. O'Brien. 1992. Trichosanthin treatment of HIV-induced immune dysregulation. Eur. J. Clin. Invest. 22:113-122.
12. Byers, V.S., A.S. Levin, L.A. Waites, B.A. Starrett, R.A. Mayer, J.A. Clegg, M.R. Price, R.A. Robins, M. Delaney, and R.W. Baldwin. 1990. A phase I/II study of trichosanthin treatment of HIV disease. AIDS. 4:1189-1196.
13. Kahn, J.O., L.D. Kaplan, J.G. Gambertoglio, D. Bredesen, C.J. Arri, L. Turin, T. Kibort, R.L. Williams, J.D. Lifson, and P.A. Volberding. 1990. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS. 4:1197-1204.
14. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
15. Moser, B., M. Loetscher, L. Piali, and P. Loetscher. 1998. Lymphocyte responses to chemokines. Int. Rev. Immunol. 16: 323-344.
16. Proost, P., A. Wuyts, and J. van Damme. 1996. The role of chemokines in inflammation. Int. J. Clin. Lab. Res. 26:211-223.
17. Strieter, R.M., P.J. Polverini, D.A. Arenberg, A. Walz, G. Opdenakker, J. van Damme, and S.L. Kunkel. 1995. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukocyte Biol. 57:752-762.
18. Friedland, J.S. 1996. Chemokines in viral disease. Res. Virol. 147:131-138.
19. Luster, A.D. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
20. Tachibana, K., S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, Y. Kataoka, Y. Kitamura, K. Matsushima, N. Yoshida, S. Nishikawa, et al. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 393:591-594.
21. Zou, Y.R., A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:595-599.
22. Furci, L., S. Polo, and P. Lusso. 1998. D8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review. J. Chemother. 10:146-149.
23. Wagner, L., O.O. Yang, E.A. Garcia-Zepeda, Y. Ge, S.A. Kalams, B.D. Walker, M.S. Pasternack, and A.D. Luster. 1998. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 391 : 908-911.
24. Littman, D.R. 1998. Chemokine receptors: keys to AIDS pathogenesis? Cell. 93:677-680.
25. Horuk, R. 1998. Chemokines beyond inflammation. Nature. 393:524-525.
26. Clapham, P.R., and R.A. Weiss. 1997. Immunodeficiency viruses. Spoilt for choice of co-receptors. Nature. 388:230-231.
27. Thornhill, M.H., and J. Li. 1997. Chemokines and chemokine receptors: the key to understanding AIDS. Oral Dis. 3:3-8.
28. Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion co-factor for macrophage-tropic HIV-i. Science. 272:1955-1958.
29. Raport, C.J., J. Gosling, V.L. Schweickart, P.W. Gray, and I.F. Charo. 1996. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 271:17161-17166.
30. Haribabu, B., R.M. Richardson, I. Fisher, S. Sozzani, S.C. Peiper, R. Horuk, H. Ali, and R. Snyderman. 1997. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J. Biol. Chem. 272:28726-28731.
31. Aramori, I., J. Zhang, S.S. Ferguson, P.D. Bieniasz, B.R. Cullen, and M.G. Caron. 1997. Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO (Eur. Mol. Biol. Organ.) J. 16: 4606-4616.
32. Zhao, J., L. Ma, Y.-L. Wu, P. Wang, W. Hu, and G. Pei. 1998. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J. Cell. Biochem. 71:36-45.
33. Alkhatib, G., M. Locati, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1997. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology. 234:340-348.
34. Simmons, G., P.R. Clapham, L. Picard, R.E. Offord, M.M. Rosenkilde, T.W. Schwartz, R. Buser, T.N.C. Wells, and A.E. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:276-279.
35. Arenzana-Seisdedos, F., J.L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moster, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Nature. 383:400.
36. Wu, L., G. LaRosa, N. Kassam, C.J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M. Parmentier, et al. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186: 1373-1381.
37. Amara, A., S.L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J.L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139-146.
38. Shaw, P.C., M.H. Yung, R.H. Zhu, W.K. Ho, T.B. Ng, and H.W. Yeung. 1991. Cloning of trichosanthin cDNA and its expression in Escherichia coli. Gene 97:267-272.
39. Zhu, R.H., T.B. Ng, H.W. Yeung, and P.C. Shaw. 1992. High level synthesis of biologically active recombinant trichosanthin in Escherichia coli. Int. J. Pept. Protein Res. 39:77-81.
40. Casellas, P., D. Dussossoy, A.I. Falasca, L. Barbieri, J.C. Guillemot, P. Ferrara, A. Bolognesi, P. Cenini, and F. Stirpe. 1988. Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxins. Eur. J. Biochem. 176:581-588.
41. Campbell, J.J., S. Qin, K.B. Bacon, C.R. Mackay, and E.C. Butcher. 1996. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J. Cell Biol. 134:255-266.
42. Gosling, J., F.S. Monteclaro, R.E. Atchison, H. Arai, C.L. Tsou, M.A. Goldsmith, and I.F. Charo. 1997. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA. 94:5061-5066.
43. Cheng, Z.J., G.H. Fan, J. Zhao, Z. Zhang, Y.L. Wu, L.Z. Jiang, Y. Zhu, G. Pei, and L. Ma. 1997. Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization. Neuroreport. 8:1913-1918.
44. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47:848-854.
45. Cai, Y.C., Y. Zhang, Y.L. Wu, and G. Pei. 1996. δ Opioid receptor in neuronal cells undergoes acute and homologous desensitization. Biochem. Biophys. Res. Commun. 219:342-347.
46. Cai, Y.C., L. Ma, G.H. Fan, J. Zhao, L.Z. Jiang, and G. Pei. 1997. Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors. Mol. Pharmacol 51:583-587.
47. 1 in neuroblastoma × glioma NG108-15 hybrid cells. FEBS Lett. 403:91-94.
48. Zhu, X., L. Ding, and G. Pei. 1997. Carboxyl terminus of mitosin is sufficient to confer spindle pole localization. J. Cell. Biochem. 66:441-449.
49. Zhao, J., G. Pei., Y.L. Huang, F.M. Zhong, and L. Ma. 1997. Carboxyl terminus of delta opioid receptor is required for agonist-dependent receptor phosphorylation. Biochem. Biophys. Res. Commun. 238:71-76.
50. Cai, G., H.-Y. Wang, E. Gao, J. Horwitz, D.L. Snyder, A. Pelleg, J. Roberts, and E. Friedman. 1997. Reduced adenosine A1 receptor and G alpha protein coupling in rat ventricular myocardium during aging. Circ. Res. 81:1065-1071.
51. Damaj, B.B., S.R. McColl, K. Neote, N. Songqing, K.T. Ogborn, C.A. Hebert, and P.H. Naccache. 1996. Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J. 10:1426-1434.
52. Proudfoot, A.E., C.A. Power, A. Hoogewerf, M.O. Montjovent, F. Borlat, and T.N. Wells. 1995. Characterization of the RANTES/MIP-1 alpha receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands. FEBS Lett. 376:19-23.
53. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1997. Nuclear factor-kappa B potendy up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol 158:3483-3491.
54. Nie, H., X. Cai, X. He, L. Xu, X. Ke, Y.B. Ke, and S.C. Tam. 1998. Position 120-123, a potential active site of trichosanthin. Life Sci. 62:491-500.
55. Cocchi, F., A.L. DeVico, A. Garzino-Demo, A. Cara, R.C. Gallo, and P. Lusso. 1997. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 3:367-368.
56. Weissman, D., R.L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J.M. Farber, and A.S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389:981-985.
57. Madani, N., S.L. Kozak, M.P. Kavanaugh, and D. Kabat. 1998. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. Proc. Natl. Acad. Sci. USA. 95: 8005-8010.
58. Rizzuto, C.D., R. Wyatt, N. Hernandez-Ramos, Y. Sun, P.D. Kwong, W.A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1949-1953.
59. Pan, K.Z., Z.J. Fu, Y.J. Lin, K.L. Zhou, E. Dodson, Z.W. Chen, and X.M. Ye. 1992. Crystallographic refinement of trichosanthin at 2.6Å resolution. Sci. China B. 35:1203-1213.
60. Pan, K.Z., Y.J. Lin, K.J. Zhou, Z.J. Fu, M.H. Chen, D.R. Huang, and D.H. Huang. 1993. The crystal and molecular structure of trichosanthin at 2.6 Å resolution. Sci. China. B. 36:1069-1081.
61. Gao, B., X.Q. Ma., Y.P. Wang, S.Z. Chen, S. Wu, and Y.C. Dong. 1994. Refined structure of trichosanthin at 1.73 Å resolution. Sci. China B. 37:59-73.
62. Cocchi, F., A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso. 1995 Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1811-1815.
63. Paul, W.E. 1995. Can the immune response control HIV infection? Cell. 82:177-182.
64. Pinching, A.J. 1990. Early trials of GLQ223/trichosanthin: what do they show? AIDS. 4:1289-1291.